SR-7A aeroelastic model design report

A scale model was designed to simulate the aeroelastic characteristics and performance of the 2.74 meter (9 ft.) diameter SR-7L blade. The procedures used in this model blade design are discussed. Included in this synopsis is background information concerning scaling parameters and an explanation of manufacturing limitations. A description of the final composite model blade, made of titanium, fiberglass, and graphite, is provided. Analytical methods for determining the blade stresses, natural frequencies and mode shapes, and stability are discussed at length

Large-scale Advanced Prop-fan (LAP) static rotor test report

Discussed is Static Rotor Testing of the SR-7L Large Scale Advanced Prop-Fan (LAP). The LAP is an advanced 9 foot diameter, 8 bladed propeller designed and built by Hamilton Standard under contract to the NASA Lewis Research Center. The Prop-Fan employs thin swept blades to provide efficient propulsion at flight speeds up to Mach .85. Static Testing was conducted on a 10,000 HP whirl rig at Wright Patterson Air Force Base. The test objectives were to investigate the Prop-Fan static aerodynamic and structural dynamic performance, determine the blade steady state stressers and deflections and to measure steady and unsteady pressures on the SR-7L blade surface. The measured performance of the LAP correlated well with analytical predictions at blade pitch angles below 30 deg. A stall buffet phenomenon was observed at blade pitch angles above 30 deg. This phenomenon manifested itself by elevated blade vibratory stress levels and lower than expected thrust produced and power absorbed by the Prop-Fan for a given speed and blade angle

Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations

Abstract Health care-associated infections (HAI) are a major public health problem with a significant impact on morbidity, mortality and quality of life. They represent also an important economic burden to health systems worldwide. However, a large proportion of HAI are preventable through effective infection prevention and control (IPC) measures. Improvements in IPC at the national and facility level are critical for the successful containment of antimicrobial resistance and the prevention of HAI, including outbreaks of highly transmissible diseases through high quality care within the context of universal health coverage. Given the limited availability of IPC evidence-based guidance and standards, the World Health Organization (WHO) decided to prioritize the development of global recommendations on the core components of effective IPC programmes both at the national and acute health care facility level, based on systematic literature reviews and expert consensus. The aim of the guideline development process was to identify the evidence and evaluate its quality, consider patient values and preferences, resource implications, and the feasibility and acceptability of the recommendations. As a result, 11 recommendations and three good practice statements are presented here, including a summary of the supporting evidence, and form the substance of a new WHO IPC guideline

Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis

Background: Catalase is an important antioxidant enzyme that regulates the level of intracellular hydrogen peroxide and hydroxyl radicals. The effects of catalase deficiency on albuminuria and progressive glomerulosclerosis have not yet been fully elucidated. The adriamycin (ADR) nephropathy model is considered to be an experimental model of focal segmental glomerulosclerosis. A functional catalase deficiency was hypothesized to exacerbate albuminuria and the progression of glomerulosclerosis in this model. Methods: ADR was intravenously administered to both homozygous acatalasemic mutant mice (C3H/AnLCs(b)Cs(b)) and control wild-type mice (C3H/AnLCs(a)Cs(a)). The functional and morphological alterations of the kidneys, including albuminuria, renal function, podocytic, glomerular and tubulointerstitial injuries, and the activities of catalase were then compared between the two groups up to 8 weeks after disease induction. Moreover, the presence of a mutation of the toll-like receptor 4 (tlr4) gene, which was previously reported in the C3H/HeJ strain, was investigated in both groups. Results: The ADR-treated mice developed significant albuminuria and glomerulosclerosis, and the degree of these conditions in the ADR-treated acatalasemic mice was higher than that in the wild-type mice. ADR induced progressive renal fibrosis, renal atrophy and lipid peroxide accumulation only in the acatalasemic mice. In addition, the level of catalase activity was significantly lower in the kidneys of the acatalasemic mice than in the wild-type mice during the experimental period. The catalase activity increased after ADR injection in wild-type mice, but the acatalasemic mice did not have the ability to increase their catalase activity under oxidative stress. The C3H/AnL strain was found to be negative for the tlr4 gene mutation. Conclusions: These data indicate that catalase deficiency plays an important role in the progression of renal injury in the ADR nephropathy model

Priority setting in health care: Lessons from the experiences of eight countries

All health care systems face problems of justice and efficiency related to setting priorities for allocating a limited pool of resources to a population. Because many of the central issues are the same in all systems, the United States and other countries can learn from the successes and failures of countries that have explicitly addressed the question of health care priorities